0000890465-13-000023.txt : 20130924 0000890465-13-000023.hdr.sgml : 20130924 20130924163010 ACCESSION NUMBER: 0000890465-13-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130920 FILED AS OF DATE: 20130924 DATE AS OF CHANGE: 20130924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BESHAR LUKE M CENTRAL INDEX KEY: 0001192128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 131112551 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-09-20 0000890465 NPS PHARMACEUTICALS INC NPSP 0001192128 BESHAR LUKE M 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 EVP & CFO Common Stcok 2013-09-20 4 M 0 45000 5.71 A 104180 D Common Stock 2013-09-20 4 M 0 5000 5.85 A 109180 D Common Stock 2013-09-20 4 S 0 14000 30.429 D 95180 D Common Stock 2013-09-20 4 S 0 19000 30.146 D 76180 D Common Stock 2013-09-20 4 S 0 12000 30.32 D 64180 D Common Stcok 2013-09-20 4 S 0 5000 30.051 D 59180 D Stock Options 5.71 2013-09-20 4 M 0 45000 0 D 2019-01-20 Common Stock 45000 0 D Stock Options 5.85 2013-09-20 4 M 0 5000 0 D 2018-10-15 Common Stock 5000 7310 D The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective August 16, 2013. On January 20, 2009, the Reporting Person received a grant of 45,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, all 45,000 stock options have vested. On October 15, 2008, the Reporting Person recevied a grant of 12,310 stock options under the Issuer's Stock 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. As of the date of this filing, all 12,310 stock options have vested. /s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact 2013-09-24